Africa Morocco Link company information, Employees & Contact Information

Navigating AML Risks in M&A: Implications of the New EU AML Package Freshfields Risk & Compliance

Know your customer: How updated rules affect M&A closings U.S. Bank

Acute Myeloid Leukemia (AML): Practice Essentials, Pathophysiology, Etiology Medscape eMedicine

Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block Nature

Wise hit with $4.2 million fine by multiple US states for AML deficiencies Finextra Research

NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity Nature

Cooperative CAR targeting to selectively eliminate AML and minimize escape ScienceDirect.com

Assessment of Minimal Residual Disease in Standard-Risk AML The New England Journal of Medicine

Recent advances in targeted therapies in acute myeloid leukemia Journal of Hematology & Oncology

Moody's Know Your Customer (KYC) & Compliance Solutions Moody's

Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia Frontiers

Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia ScienceDirect.com

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML The New England Journal of Medicine

Polymorphisms in immunosuppression-related genes are associated with AML Frontiers

A new genomic framework to categorize pediatric acute myeloid leukemia Nature

Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia ScienceDirect.com

Targeting PRAME for acute myeloid leukemia therapy Frontiers

Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial Nature

Regulation of HOX gene expression in AML Nature

What have we learned about TP53-mutated acute myeloid leukemia? | Blood Cancer Journal Nature

PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway Nature

A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia ScienceDirect.com

Targeting CD38 for acute leukemia Frontiers

Predicting the influence of Circ_0059706 expression on prognosis in patients with acute myeloid leukemia using classical statistics and machine learning Frontiers

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML Nature

Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis Nature

Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib | Blood Cancer Journal Nature

Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML Nature

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation The New England Journal of Medicine

Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia Frontiers

-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia Nature

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia The New England Journal of Medicine

Research progress on molecular biomarkers of acute myeloid leukemia Frontiers

Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia Nature

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia ScienceDirect.com

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes The New England Journal of Medicine

Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate Nature

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting Nature

Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias Nature

Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies | Scientific Reports Nature

to increase oral bioavailability and chemotherapeutic efficacy in AML mice Nature

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia Nature

Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data Frontiers

SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML Nature

Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a -mutant clonal hematopoiesis Nature

The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China Wiley Online Library

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia Nature